Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
2015 ◽
Vol 60
(3)
◽
pp. 1899-1901
◽
Keyword(s):
Extended-infusion ceftolozane-tazobactam treatment at 1.5 g every 8 h was used to treat multidrug-resistantPseudomonas aeruginosain a critically ill patient on continuous venovenous hemofiltration. Serum drug concentrations were measured at 1, 4, 5, 6, and 8 h after the start of infusion. Prefilter levels of ceftolozane produced a maximum concentration of drug (Cmax) of 38.57 μg/ml, concentration at the end of the dosing interval (Cmin) of 31.63 μg/ml, time toCmax(Tmax) of 4 h, area under the concentration-time curve from 0 to 8 h (AUC0–8) of 284.38 μg · h/ml, and a half-life (t1/2) of 30.7 h. The concentrations were eight times the susceptibility breakpoint for the entire dosing interval.
2014 ◽
Vol 59
(1)
◽
pp. 46-52
◽
2017 ◽
Vol 16
(2)
◽
pp. 117-119
◽
2017 ◽
Vol 38
(2)
◽
pp. e17-e21
◽
2013 ◽
Vol 57
(11)
◽
pp. 5714-5716
◽
Keyword(s):
2005 ◽
Vol 49
(6)
◽
pp. 2421-2428
◽
2016 ◽
Vol 60
(9)
◽
pp. 5454-5458
◽